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Abstract 
Differential tissue sensitivity/responsivity to hormones can explain developmental asynchrony among hormone-
dependent events despite equivalent exposure of each tissue to circulating hormone levels. A dramatic vertebrate 
example is during frog metamorphosis, where transformation of the hind limb, brain, intestine, liver, and tail are 
completely dependent on thyroid hormone (TH) but occurs asynchronously during development. TH transporters 
(THTs) and cytosolic TH binding proteins (CTHBPs) have been proposed to affect the timing of tissue transformation 
based on expression profiles and in vitro studies, but they have not been previously tested in vivo. We used a 
combination of expression pattern, relative expression level, and in vivo functional analysis to evaluate the potential for 
THTs (LAT1, OATP1c1, and MCT8) and CTHBPs (PKM2, CRYM, and ALDH1) to control the timing of TH-
dependent development. Quantitative PCR analysis revealed complex expression profiles of THTs and CTHBPs with 
respect to developmental stage, tissue, and TH receptor β (TRβ) expression. For some tissues, the timing of tissue 
transformation was associated with a peak in the expression of some THTs or CTHBPs. An in vivo overexpression 
assay by tail muscle injection showed LAT1, PKM2, and CRYM increased TH-dependent tail muscle cell 
disappearance. Co-overexpression of MCT8 and CRYM had a synergistic effect on cell disappearance. Our data show 
that each tissue examined has a unique developmental expression profile of THTs and CTHBPs and provide direct in 
vivo evidence that the ones tested are capable of affecting the timing of developmental responses to TH. 
 
1. Introduction 
At some point during post-embryonic development in all vertebrates, a peak in blood levels of thyroid hormone (TH) 
occurs and induces critical TH-dependent developmental events (Buchholz et al., 2006). TH regulates developmental 
events by binding with TH receptors (TRs) in the cell nucleus and changing gene expression, leading to extensive 
morphological and/or functional changes in TH-target tissues (Shi, 1999). Importantly, even though organs and tissues 
are exposed to the same circulating levels of TH, TH-dependent events occur at different time points during 
development, that is, in a tissue asynchronous manner (Brown et al., 2005; Furlow and Neff, 2006). A dramatic 
example of TH-dependent tissue asynchrony is frog metamorphosis, where TH induces (1) hind limb elongation at the 
start of metamorphosis when TH levels are low, (2) tail resorption during metamorphic climax when TH levels peak, 
and (3) TH-dependent remodeling of the other organs when TH levels are intermediate. 
Tissue asynchrony is due to a combination of (1) differential sensitivity to TH, i.e., tissues differ in the blood 
concentration of TH required to initiate TH-dependent gene expression and tissue transformation and (2) differential 
responsivity to TH, i.e., tissues differ in rate of TH-dependent tissue transformation (Shi et al., 1996). Above a 
threshold TH concentration in the blood, a tissue becomes sensitive to transform, and the response to TH (rate of 
transformation) is proportional to the amount of TH signaling and constrained by the inherent tissue-specific rate of 
developmental change. Sensitivity and responsivity are related, because both depend on mechanisms that regulate TH 
entry into the cell from circulation, transport across the plasma membrane, transit through the cytoplasm, and binding 
of TRs in the cell nucleus to regulate gene expression (Buchholz et al., 2011). At least four candidate mechanisms are 
known or hypothesized to affect tissue sensitivity/responsivity, based on expression and activity levels of (1) TR and 
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associated transcription co-factors, (2) TH metabolizing enzymes (deiodinases), (3) TH transport from the blood across 
the plasma membrane, and (4) cytosolic TH binding proteins (Shi et al., 1996). Previous in vivo functional analyses on 
deiodinase type 3 (Huang et al., 1999), TRs (Buchholz et al., 2004; Choi et al., 2015; Hollar et al., 2011; Nakajima et 
al., 2012), and various transcription factors (Matsuda et al., 2009; Paul et al., 2007; Sato et al., 2007) using 
overexpression by transgenesis or tail muscle cell injection showed changes in timing of tissue development, i.e., 
affected tissue sensitivity and responsivity to TH (Hollar et al., 2011). However, the role of TH transporters (THTs) and 
cytosolic TH binding proteins (CTHBPs) that may also impact TH signaling has not been experimentally examined in 
vivo. 
Many THTs have been identified, including monocarboxylate transporters (MCT8, MCT10), L-type amino acid 
transporters (LAT1, LAT2), and organic anion transporting proteins (OATP1c1, OATP1A2 and OATP4A1) (Friesema 
et al., 2008, 2003; Hennemann, 2001; Pizzagalli et al., 2002). Different THTs have different transport efficiencies and 
specificities for TH, where MCT8, MCT10, and OATP1c1 have the highest affinity and specificity for TH transport, 
and LAT1 and 2 serve to transport subsets of amino acids as well as iodothyronines (Heuer and Visser, 2009). In-vitro 
studies have shown that LAT1 enhances TR-mediated gene transcription in a Xenopus oocyte transcription assay 
(Ritchie et al., 2003; Shi et al., 2002). In addition, LAT1 is strongly up-regulated during TH-dependent development, 
suggesting that it may play an important in vivo role in TH signaling (Liang et al., 1997). The strongest evidence for an 
in vivo role of TH transport comes from the association of mutations in MCT8 with severe X-linked mental retardation 
and elevated circulating levels of T3, the active form of TH (Jansen et al., 2008). Most TH transporters are expressed in 
varying patterns in different types of tissues in mammals (Heuer and Visser, 2009) and frogs (Connors et al., 2010). 
However, there has been no direct evidence that THTs play a role in control of developmental asynchrony. 
Cytosolic TH binding proteins (CTHBPs) were first identified as distinct from serum TH binding proteins (Tata, 1958) 
and are now well-established in mammals and amphibians (Yamauchi and Tata, 2001). The CTHBPs identified to date 
do not represent a specific protein family but rather are diverse, multifunctional proteins (Yamauchi and Tata, 2001). In 
frogs, two CTHBPs have been identified: aldehyde dehydrogenase 1 (ALDH1) and pyruvate kinase subtype M2 
(PKM2) (Shi et al., 1994; Yamauchi and Tata, 2001). Two other CTHBPs in frogs have been detected but not identified 
(Yamauchi and Tata, 1997; Yoshizato and Frieden, 1975). ALDH1 catalyzes aldehyde oxidation and synthesis of 
retinoic acid and was independently identified as a cytosolic TH binding protein (Yamauchi and Tata, 1994). TH 
interacts with ALDH1 as a non-competitive inhibitor of dehydrogenase activity (Yamauchi and Nakajima, 2002). 
PKM2, a central player in cellular energy metabolism, was identified as a CTHBP by protein purification of TH 
binding activity (Kitagawa et al., 1987). PKM2 exists in the cytoplasm as a tetramer (high enzymatic activity) or 
monomer (low enzymatic activity), depending on posttranslational modifications and allosteric regulators. The 
presence of fructose 1,6-bisphosphate and serine favors the tetrameric form and allosterically activates PKM2, whereas 
phenylalanine and T3 favor the monomer and allosterically inhibit PKM2 (Christofk et al., 2008; Gui et al., 2013; 
Morgan et al., 2013; Williams et al., 2006). Though not studied previously in amphibians, CRYM was discovered first 
as a CTHBP and was much later found to have NADH/NADPH-dependent ketimine reductase activity, involved in 
lysine catabolism, and T3 strongly and non-competitively inhibits this enzyme activity (Hallen et al., 2011). CRYM 
mutations are associated with deafness in humans, with a link to TH signaling (Oshima et al., 2006). In mouse, CRYM 
knockout affected serum and tissue T3 turnover but not peripheral T3 action in vivo, and there was no effect on mouse 
hearing (Suzuki et al., 2007). 
The mechanisms of CTHBP action in TH signaling are not known, but CTHBPs may shuttle TH to the nucleus to 
facilitate TH signaling or sequester TH in the cytoplasm and reduce TH signaling (Shi et al., 1996). Indeed, CRYM can 
increase cytoplasmic T3 retention and can suppress T3-induced gene expression in cell culture (Mori et al., 2002). 
Similarly, PKM2 or CRYM expression is negatively correlated with induction of TH response genes (Ashizawa and 
Cheng, 1992; Mori et al., 2002; Shi et al., 1994). On the other hand, TH-induced gene regulation was not affected by 
MCT8 alone but was increased in combination with CRYM (Van Mullem et al., 2011). Also, a positive correlation 
exists between cytosolic T3-binding activity from unidentified proteins and metamorphic changes in hind limb, 
intestine, head, and liver, but not in tail (Yamauchi and Tata, 1997). Equilibrium dissociation constants (Kd) among 
known CTHBPs for TH range from 0.1 nM to over 100 nM, indicating that some CTHBPs may be of only 
pharmacological importance and not relevant at physiological TH levels (Yamauchi and Tata, 2001). Also, the ability 
of T3 to inactivate enzyme activity of CTHBPs suggests that a potential role of an interaction between CTHBPs and 
TH may be to modulate enzyme activity in addition to modulate intracellular TH bioavailability for transcription 
regulation. 
Here, we address the role of THTs and CTHBPs in tissue-specific regulation in TH-dependent development in frog 
metamorphosis using expression and functional analyses. We quantified expression profiles of three THTs (LAT1, 
MCT8 and OATP1c1) and three CTHBPs (PKM2, ALDH1 and CRYM) in five TH-target tissues/organs (hind limb, 
liver, intestine, brain, and tail) at seven developmental stages throughout the larval period including metamorphosis. 
Also, we overexpressed THTs (LAT1 and MCT8) and CTHBPs (PKM2 and CRYM) in tail muscle cells to determine 
the effect on the rate of TH-dependent muscle cell disappearance. 
 
2. Materials and methods 
2.1. Animal care and rearing 
Breeding was induced by injecting human chorionic gonadotropin (Sigma Aldrich, St. Louis, MO) into Xenopus tropicalis (20 U in the evening 
followed by a 200 U booster in the morning for both sexes) and into Xenopus laevis (600 U in females and 100 U in males in the evening). 
Tadpoles were reared and staged according to Nieuwkoop and Faber (NF) (Nieuwkoop and Faber, 1994) until tissue harvest and/or tail 
injection. Tadpoles were reared at 25 °C and 19 °C for X. tropicalis and X. laevis, respectively, and fed powered food (Sera Micron) with daily 
water changes. The use of animals in this study was approved by the University of Cincinnati Institutional Animal Care and Use Committee 
(IACUC protocol # 06-10-03-01). 
2.2. RNA isolation, cDNA synthesis, and quantitative PCR 
Hind limb, brain, liver, intestine, and tail from staged tadpoles anesthetized in benzocaine (Sigma) were isolated, snap frozen on dry ice, and 
then stored at −80 °C until RNA isolation. The intestine was flushed of its contents using a 30-gauge needle filled with phosphate buffered 
saline at 60% mammalian strength prior to freezing. Three to six replicates were obtained, but for smaller organs, each replicate was pooled 
from 2 to 3 individuals. Total RNA was isolated using TRIzol (Invitrogen) according to manufacturer’s instructions. Two μg of RNA were 
used to synthesize cDNA, following the manufacturer’s protocol (Multiscribe reverse transcriptase kit, Applied Biosystems). Quantitative PCR 
(qPCR) was carried out with 1–2 μL cDNA in 20 μL reactions using FAM-labeled primer/probe sets (Table 1) and Universal Master Mix 
(Applied Biosystems) on a 7300 Real Time PCR System with default reaction conditions (50 °C 2 min, 95 °C 10 min, then 40 cycles of 95 °C 
10 s, 60 °C 1 min) (Applied Biosystems). qPCR standards (1:3 serial dilutions) were made from NF stage 62 whole body tadpole mRNA and 
used to quantify relative expression levels among stages and tissues. qPCR runs where slopes of the standard curves (generated using serial 
dilutions of cDNA from NF62 whole bodies) were outside the range of −3.40 to −3.90 (a slope of −3.54 reflects 100% amplification efficiency) 
and R2 values were less than 0.990 were not included in the analyses. A control sample (1/30 dilution of cDNA from NF62 whole bodies) was 
included in each qPCR run and used to evaluate the consistency among runs. Non-template controls were used in each qPCR run and failed to 
detect reaction product contamination. Each replicate was run in duplicate in qPCR, and the values were averaged for expression analysis. 
Table 1. Quantitative PCR primers and probes for TRβ, THTs and CTHBPs. 
Gene Forward primer (5′–3′) Reverse primer (5′–3′) FAM-labeled probe (5′–3′) Product (bp) 
TRβ CAAGAGTTGTTGATTTTGCCAAAAAGC ACATGATCTCCATACAACAGCCTTT CTGCCATGTGAAGACC 98 
rpL8 AGAAGGTCATCTCATCTGCAAACAG CTTCAGGATGGGTTTGTCAATACGA CAACCCCAACAATAGCT 80 
LAT1 GTTCGCTACCTACCTGCTCAAG CCTGGTAGCTGCTTTCACACT CAGTCAGCAGCAAGATA 133 
MCT8 ACCGAGGAACAGGGTATGGA ACAACTGGAGAGCAGAAAAAGATCA CCAACCCAAGCTGTCTTG 83 
OATP1c1 GGCATTTACACACTGGTCATACG GCGCCCCCAGGTACATG ATCCCCGCAAGAACC 64 
Gene Forward primer (5′–3′) Reverse primer (5′–3′) FAM-labeled probe (5′–3′) Product (bp) 
PKM2 GGGAGACTGCAAAGGGAGACTA GGTGGAAAATGGCTGCTTCTG ATGCAGCATGCTATTGC 87 
CRYM CGGCAGTTTCAGCAATAGCAA GATCCCAGAATGCACAAGATTTCAG CAAAGCTCCTTAAGCCC 70 
ALDH1 GCCTGTTGGAGTAT GGAGCAATTTTCCA AATCCCATGGAACTTTC 72 
 
2.3. Cloning of plasmid constructs for tail injections 
LAT1, MCT8, PKM2, and CRYM were PCR amplified (primers in Table 2) from a X. tropicalis cDNA library made for gene expression 
analysis above or from pBluescript SK(−)_LAT1 (IU12) and _PKM2 (gifts from Dr. Y.-B. Shi) and cloned into the SacII site of pHGCR-lox to 
replace DsRed2. The pHGCR-lox plasmid (sequence is available on request) was made by standard cloning techniques and gene synthesis 
(DNA2.0). To make pHGC-CRYM-C-MCT8-lox, we designed an oligo linker (5′ GGCCGCGCGC 3′) and ligated it into the NotI site of 
pHGC-MCT8-lox to generate one more BssHII site, from which the C-MCT8 fragment was subcloned into pHGC-CRYM-lox to make pHGC-
CRYM-C-MCT8-lox. Plasmid DNA was purified using Plasmid Maxi prep kit (Qiagen) and precipitated with sodium acetate and ethanol. 
Table 2. Primers for subcloning THTs and CTHBPs into expression plasmids for tadpole tail muscle injections. 
Gene 
(species) 





CATCATCCGCGGGCCACCATGGCCGCAGACAGCGTG CATCATCCGCGGTTAGGACTCCTGGGGGACAGCC 1524 
MCT8 (X. 
tropicalis) 
CATCATCCGCGGGCCACCATGGAAGAAGAAGCAGAAGAGGACGAG CATCATCCGCGGCTACACACATTCATCTGTTACTGGGCTCCC 1500 
PKM2 (X. 
tropicalis) 




CATCATGCGCGCGTCGACACCGGTCCGCGGGCCACCATGGGCGAGCAGCCGGCTTT CATCATGCGCGCCCGCGGTCATTTATTTTCAGCCAGCCAGGA 934 
ALDH1 
(X. laevis) 
CATCATACCGGTATGTCAGAGAAAACCATTCTACATGGTTTGCC CATCATAGATCTTTAGGAATTCTTCTGAGAAATTTTCATGATAACCG 1520 
 
2.4. Tail muscle injections 
Tadpoles of X. laevis reared in stock tanks until NF stage 54–56 were pre-heat shocked at 32 °C for 5 min. The next day, tadpoles were briefly 
anesthetized in benzocaine and injected with the control plasmid pHGCR on the left side and a THT or a CTHBP expression plasmid (see 
Fig. 3A) on the right side of the tail, as described previously (Hollar et al., 2011). Briefly, 0.5 μL of DNA (2 μg/μL), containing 0.05% w/v fast 
green dye (Sigma), was injected into two myomeres on each side of the tail. Tadpoles were given daily heat shocks at 33–34 °C for an hour to 
induce gene expression beginning the day of injection. Treatment with 2 nM T3 started on the day after tail injection. 2 nM T3 is near the 
sensitivity threshold for the tail and was chosen to increase the ability of the assay to detect effects of overexpressed genes that increased the 
effect of T3. The experiments using LAT1 and MCT8 were conducted 2–3 times with comparable results, and thus the experiments with 
PKM2, CRYM, CRYM + MCT8 were each conducted once. The number of tadpoles injected, the number of cells per tadpole, and the total 
number of cells per hormone treatment per gene are enumerated in Suppl. Table 1. Cell fluorescence appeared to reach a maximum intensity 
and maximum cell number five days after plasmid injection, thus from day 5 to 14, GFP-positive cells in the tail muscle were imaged daily 
using a fluorescent microscope and counted manually to determine the rate of cell disappearance. The disappearance of any one cell was not 
gradual but occurred within 24 h. Water and hormone were changed daily. 
To confirm THT and CTHBP mRNA expression from injected plasmids, each plasmid (i.e., control, LAT1, MCT8, PKM2, CRYM, and 
MCT8 + CRYM) was injected into multiple sites on a NF56–57 tadpole tail followed by daily heat-shock to induce GFP expression. Tail 
tissues in the region of injection were then harvested on the fifth day after injection to isolate RNA, synthesize cDNA, and measure LAT1, 
MCT8, PKM2, CRYM, and the reference gene rpL8 by qPCR. Two to three tadpoles were used for each plasmid. To analyze data, the ddCt 
method was used (Livak and Schmittgen, 2001). 
 
2.5. Statistical analysis 
Gene expression data were tested for normality and heteroskedasticity and conformed to assumptions of analysis of variance (ANOVA) (JMP 
Statistical software). ANOVA was performed to determine if there were significant differences among stages of development (Table 3). The 
threshold P-value of significance was set at 0.05. For any tissue and gene that yielded a P-value of 0.05 or less, a post hoc, pair-wise 
comparison was performed using the Tukey–Kramer method. To test for a significant effect of THT and CTHBP on cell disappearance, a 
generalized linear mixed model (GLMM) was used (Bates et al., 2012; Marschner, 2012; The R Core Team, 2013). In our data, there are n 
trials in each tail (i.e., total number of GFP positive muscle cells), and x number of “successes” (i.e., cells disappearing). Our response variable 
is the percent of muscle cells surviving, as calculated by y = 100 * x/n. Thus, GLMM analysis is appropriate and ANOVA is not (Warton and 
Hui, 2011). In the model, injected gene, TH treatment, and their interaction were fixed effects, and individual tadpoles and time (treatment 
days) were random effects. We evaluated which effects affected the rate of disappearance of fluorescent cells in tadpole tail muscle. 
Table 3. Statistical analysis of THT and CTHBP expression levels in different tissues across developmental stages. 
Gene Statistics Brain Hind limb Intestine Liver Tail 
LAT1 
F 0.9199 5.5079 5.237 1.869 2.0587 
n 3–5 3–5 4–6 5–6 4–6 
OATP1c1 
F 6.9451 6.8307 3.9326 4.4839 3.4851 
n 3–5 3–5 4–6 5–6 4–6 
MCT8 
F 2.2519 8.4057 5.5618 10.4579 39.9546 
n 3–5 3–5 4–6 5–6 4–6 
CRYM 
F 6.9571 15.557 4.1552 2.9006 20.4657 
n 3–5 3–5 4–6 5–6 4–6 
PKM2 
F 2.2002 13.6944 4.0911 0.4977 21.945 
n 3–5 3–5 4–6 5–6 4–6 
ALDH1 
F 1.5814 4.9732 7.4861 7.6153 2.0967 
n 3–5 3–5 4–6 5–6 4–6 
Statistics: one-way ANOVA, F = F statistic, n = sample size across stages for each gene and tissue, highlighted bold F values indicate 
statistical significance (P < 0.05) across stages for that gene and tissue. 
 
3. Results 
3.1. TRβ and rpL8 
To examine the potential functional significance of THTs and CTHBPs with respect to the sensitivity/responsivity of a tissue to TH, we 
obtained the profile of the TH-response gene TRβ for comparison with expression profiles of THTs and CTHBPs. For any one tissue, the 
expression of TRβ mRNA is expected to peak at the initiation of TH-dependent morphological change. Indeed, the developmental profiles of 
TRβ for the intestine and tail follow this pattern (Fig. 1A). However, the hind limb and brain show among the earliest TH-dependent changes 
(NF52–54), but the TRβ peak occurred later at NF58 and NF62, respectively (Shi, 1999). Similarly, the liver expresses TH-induced urea cycle 
enzymes at climax of metamorphosis (NF62) (Helbing et al., 1992), but the TRβ peak occurred after that at NF64. 
 
Fig. 1. Quantification of TRβ and rpL8 mRNA among tissues during natural metamorphosis. Tadpoles of Xenopus tropicalis were staged, 
tissues were harvested (hind limb, brain, intestine, liver, tail), and total RNA and cDNA were prepared. Expression of TRβ (A) and rpL8 (B) 
were measured by quantitative PCR. Standard error is indicated with a bar at each time point, n = 3–6. Post hoc pair wise comparisons (Tukey–
Kramer) were conducted within tissues across developmental stages, and letters in the tables represent significance groups within tissues. 
Gray/bold cells in the table indicate stage at peak TRβ expression for each tissue. The black box indicates absence of data for the tail, which 
has resorbed completely by NF66. Numbers in the tables represent fold changes in TRβ expression comparing the levels between NF54 and 
stage of the TRβ peak for each tissue. 
As reported previously (Dhorne-Pollet et al., 2013; Duarte-Guterman et al., 2010; Sindelka et al., 2006), we found that 
rpL8 values do not remain constant across stages or tissues (Fig. 1B). Thus, analyses of TRβ and the THTs and 
CTHBPs were not normalized to a housekeeping gene to avoid introducing undesirable biases. Rather, each cDNA 
sample used for qPCR was synthesized using the same amount of total RNA, and relative expression levels were 
calculated as the average of 3–6 samples per stage and tissue. 
3.2. TH transporters 
3.2.1. LAT1 
Comparison of expression across tissues revealed that brain expressed significantly more LAT1 than the other tissues and that only hind limb 
and intestine had significantly different expression levels across stages (Fig. 2A, Table 3). For the intestine, LAT1 expression was similar 
across stages until a 16-fold increase at NF66 compared to NF54 but showed no significant increase at the stage of peak intestinal TRβ 
expression. In the hind limb, high levels of LAT1 expression corresponded to the peak in TRβ expression, with nearly 6-fold expression level 





Fig. 2. Quantification of THT and CTHBP mRNAs among tissues during natural metamorphosis in Xenopus tropicalis. The same samples and 
statistical analyses were used as in Fig. 1. For the THTs, LAT1, OATP1c1 and MCT8 (A–C) and CTHBPs, CRYM, PKM2 and ALDH1 (D–F), 
the peak in mRNA expression is indicated by a gray box for each tissue. TRβ peaks are indicated by bold boxes to compare timing of 
expression peaks with the TH signaling genes. 
 
3.2.2. OATP1c1 
Expression levels of OATP1c1 varied across stages for each tissue except intestine (Fig. 2B, Table 3). Like LAT1, OATP1c1 was highly 
expressed in the brain compared to the other tissues and remained high through NF63, followed by a 2-fold decrease. In the hind limb, 
OATP1c1 was initially high at the time of limb growth initiation then showed a 35-fold decrease at NF58 and then remained low. Liver and tail 
maintained relatively low levels of OATP1c1 expression throughout the larval period. In no tissue did an OATP1c1 peak match the TRβ 
expression peak for that tissue, though the hind limb and tail OATP1c1 peaks were one stage before the corresponding TRβ peak. 
3.2.3. MCT8 
Expression levels of MCT8 varied across stages for each tissue except brain (Fig. 2C, Table 3). The peaks in MCT8 expression roughly 
matched the stage of transformation in hind limb, intestine, and tail but not in liver. The fold change expression from NF stage 54 to expression 
peak varied among tissues with the greatest fold change in the tail (16-fold increase) and hind limb (14-fold decrease), followed by the intestine 
(7-fold increase) and liver (2-fold decrease). 
3.3. Cytosolic TH binding proteins 
3.3.1. CRYM 
Expression of CRYM changed significantly with distinct profiles across stages for each tissue (Fig. 2D, Table 3). CRYM expression peaks for 
brain and hind limb occurred one stage before the TRβ peak, but had the opposite pattern in intestine. CRYM expression increased in tail 
during tail resorption. Overall expression levels in the liver were low compared to other tissues. 
3.3.2. PKM2 
The expression profile of PKM2 significantly increased in hind limbs and decreased in intestine and tail (Fig. 2E, Table 3), and these changes 
were inversely correlated with the corresponding TRβ peak in hind limb and tail. Brain and liver showed no significant change in PKM2 
expression during the stages tested. 
3.3.3. ALDH1 
Intestine and liver had high expression levels that declined as development progressed, compared to the other tissues, which had low and 
usually non-significant changes across development (Fig 2F, Table 3). The decreases in ALDH1 expression coincided with the timing of 
metamorphic changes in liver and intestine and were inversely related to the peak in TRβ expression. 
3.4. In-vivo gene function study in tadpole tail muscle 
To test direct effects of TH signaling proteins in TH-dependent development in vivo, plasmids encoding LATI, PKM2, MCT8, CRYM, 
MCT8 + CRYM, or control DsRed2 fluorescent protein under transcriptional control of the ubiquitous promoter CMV (cytomegalovirus) were 
injected into tadpole tail muscle cells using somatic gene transfer system (De Luze et al., 1993; Sachs et al., 2004) (Fig. 3A). Fluorescent 
protein expression marked cells that received the plasmids in order to monitor their cell disappearance by daily monitoring using a fluorescence 
microscope (Fig. 3B). A set of tadpoles was used to test the overexpression of THTs and CTHBPs on day 5, and qPCR measurements of 
mRNA levels confirmed their overexpression in injected tails (Suppl. Table 2). As expected with the low dose of T3, the amount of cell 
disappearance in control-injected tails was slightly more in the 2 nM T3 compared to the 0 nM T3 treatment (Fig. 4, compare solid and dashed 
lines lacking symbols in all the panels). Also, substantial variation was observed among individual tadpoles in most of the experiments, but 
treatment day had low variation across experiments (Table 4, see Random Effects sections of table). 
 
Fig. 3. Diagrams of constructs used to overexpress target genes and exemplar images of tail muscle cells. (A) Expression of green fluorescent 
protein (GFP) was under the control of the heat shock-inducible promoter (HSP), and expression of DsRed2 and genes encoding THTs, 
CTHBPs was under the control of the ubiquitous cytomegalovirus (CMV) promoter. GFP was used as a marker to monitor cell disappearance. 
(B) Tails injected with the pHGC-LAT1 construct were treated with T3 (0 or 2 nM) starting on Day 2, and imaged on treatment day 5 and 12. 





Fig. 4. Effect of THT and CTHBP overexpression in TH-dependent tail muscle cell disappearance. Overexpression of LAT1 (A), PKM2 (B), 
MCT8 (C), CRYM (D), and MCT8 + CRYM (E) was achieved by injection of expression plasmids into tail muscle at NF56. Expression 
cassettes for a fluorescent protein on the same plasmid enabled observation of muscle cells overexpressing a THT or CTHBP. Injection on the 
opposite side of the tail of a plasmid that only expresses fluorescent proteins served as the control for the absence of overexpressed THT or 
CTHBP. Injected tadpoles were treated with 0 or 2 nM T3 daily for 14 days, and counts of muscle cells expressing fluorescent proteins were 
conducted daily from Day 5 to Day 14. Cell disappearance was quantified as the percent of the number of fluorescent cells on a particular day 
compared to the number of fluorescent cells on Day 5. The effect of T3 was to reduce the number of fluorescent cells to 60–80%, and 
overexpression of THTs or CTHBPs in the presence of T3 reduced the percent of fluorescent cells to 20–40% depending on the gene. In the 
absence of T3, percent of fluorescent cells remained above 80% in the controls and ranged from 60% to 80% across overexpressed THTs and 








Bold values indicate significance at a level of α < 0.05. 
LAT1, PKM2, and CRYM had similar patterns of cell disappearance among treatments (Fig.4A, B and D). In the 
absence of T3, overexpression of these genes had a similar effect on muscle cell disappearance compared to the control 
muscle cells injected on the opposite side of the tail. However, in the presence of T3, cell disappearance was greater in 
tails with overexpression of these genes compared to control-injected tails. The generalized linear mixed model 
statistical analysis showed that all three fixed effects, i.e., Gene, TH treatment, and Gene × TH interaction had 
significant effects on cell disappearance in tadpole tail muscle (Table 4). Thus, LAT1, PKM2, and CRYM 
overexpression increased the amount of cell disappearance induced by T3. 
For MCT8, the rate of cell disappearance in the MCT8-injected tails paralleled that in the control tails in the absence 
and presence of T3 (Fig. 4C). The generalized linear mixed model statistical analysis showed that the fixed effects, 
Gene and TH treatment but not Gene × TH interaction, had significant effects on cell disappearance (Table 4). Thus, 
MCT8 had a slight but significant effect on cell disappearance but did not increase T3-induced cell disappearance. 
Co-overexpression of MCT8 and CRYM greatly increased rate of tail muscle cell disappearance in the absence and 
presence of exogenous T3 treatment (Fig. 4E). The generalized linear mixed model showed that only the fixed effect, 
Gene and not TH treatment or Gene × TH interaction, had a significant effect on cell disappearance (Table 4). Thus, 
MCT8 + CRYM significantly increased cell disappearance but the high variation in the experiment precluded the 
ability to detect a statistically significant effect of TH or of a Gene × TH interaction. 
 
4. Discussion 
The THT and CTHBP expression patterns observed were consistent with those in previous studies examining mRNA 
profiles, in cases where there was overlap among studies in developmental stages and organs (Connors et al., 2010; Shi 
et al., 1994). To evaluate their potential contribution to the timing of tissue transformation, the THT and CTHBP 
expression profiles were compared to those of TRβ. TRβ autoinduction is a sensitive molecular indicator of TH 
signaling that presages morphological transformation in many tissues (Tata, 2000). Indeed, the TRβ expression profile 
peaked at developmental stages coinciding with initiation of metamorphic changes in brain, intestine, and tail. 
However, hind limb TRβ expression peaked at NF58, even though TH-dependence of hind limb development begins at 
NF54. The explanation for this discrepancy is not clear, but previous RT-qPCR data for hind limb TRβ expression 
showed a similar developmental profile (Wang et al., 2008). Also, liver TRβ mRNA levels gradually increased to a low 
peak at NF64, but the explanation is unknown for the lack of correspondence with TH-dependent induction of urea 
cycle enzymes, which occurs at climax of metamorphosis (Atkinson et al., 1996). 
For any given tissue, we hypothesized that a high expression level of a THT potentially involved in tissue sensitivity to 
TH would correspond to or immediately precede the TRβ peak and initiation of metamorphic change. Our data show 
that expression peaks for LAT1 in hind limb, OATP1c1 in hind limb and brain, and MCT8 in hind limb and tail 
corresponded to the TRβ expression peaks, thereby strengthening the link between THT expression and timing of tissue 
transformation in those cases. For CTHBPs, we expected a trough for CTHBPs at the TRβ peak if they act to sequester 
TH in the cytoplasm inhibiting TH movement to the nucleus. On the other hand, CTHBPs may act as a delivery system 
from the cell surface to the nucleus, in which case the CTHBP and TRβ peaks may correspond. The pattern of CRYM 
mRNA expression was consistent with that of a delivery system in hind limb, brain, and tail. Expression of PKM2 in 
hind limb, intestine, and tail and ALDH1 in intestine was consistent with a sequestering role. However, for most 
tissues, expression of THTs and CTHBPs either was not significant across stages or did not correspond to the TRβ 
peak, signifying a lack of evidence one way or the other that they play a role in tissue asynchrony in those tissues. 
Several caveats are important when inferring biological significance of mRNA expression levels for tissue sensitivity 
and developmental asynchrony. Importantly, even though mRNA expression levels are suggestive of the degree of 
involvement in tissue sensitivity, protein expression and activity levels, which may or may not correspond to mRNA 
levels, directly determine the effect of THTs and CTHBPs. Indeed, our ALDH1 mRNA expression pattern did not 
correspond to T3 binding activity which was previously shown to increase gradually in liver and intestine during 
metamorphosis (Yamauchi and Tata, 1997). Also, our measurements using whole organs such as the brain may obscure 
significant expression changes important in subsets of cells for tissue sensitivity. Furthermore, lack of correspondence 
between THT/CTHBP and TRβ mRNA expression we observed does not preclude participation in control of tissue 
asynchrony because even steady levels of THT/CTHBP expression may trigger tissue transformation at a particular 
point in time corresponding to a threshold level of the rising TH titer. Thus, though suggestive, mRNA expression 
patterns and levels by themselves are not definitive evidence for a role in regulation of tissue sensitivity to TH and 
developmental asynchrony. 
Functional studies provide a complementary approach to assess THT or CTHBP involvement in TH signaling. We used 
a tail injection assay involving a standard form of GFP whose protein lasts for weeks in vivo (Kerney et al., 2012) to 
determine the effect of THT or CTHBP overexpression on metamorphic change, i.e., TH-dependent tail muscle cell 
disappearance. The loss of GFP signal from a muscle cell within 24 h is considered strong evidence of cell death 
(Hollar et al., 2011; Nakajima et al., 2012). Such cell disappearance observed is likely via cell death by apoptosis 
because the cells disappear within one day rather than gradually decreasing in GFP fluorescence and because TH is 
well known to induce apoptosis in tail muscle cells (Nakajima and Yaoita, 2003). From the above expression studies, 
endogenous levels of THTs and CTHBPs in the tail were likely to be low favoring the chance that tail muscle would be 
a good test tissue. Also, we used a dose of T3 close to the threshold level of sensitivity for the tail, which favors 
detecting an increase in response to TH. Decreased responses to TH potentially due to CTHBPs are less likely to be 
measured. The multiple protein activities of THTs (transport amino acids in addition to TH) and CTHBPs (have 
enzymatic activity in addition to binding TH) complicate interpretation, such that any increase in cell death may not be 
via TH signaling but due to altered amino acid transport or enzyme activity. However, lack of induction of cell 
disappearance by THT or CTHBP overexpression in the absence of T3 would argue against toxicity or alteration of cell 
function causing cell death. 
For LAT1, consistent with in vitro assays measuring TH gene regulation (Ritchie et al., 2003; Shi et al., 2002), LAT1 
increased the rate of tail cell disappearance in a T3-dependent manner suggesting that LAT1 can increase TH signaling 
in vivo. Alternate interpretations have not been formally ruled out that the increased amino acid transport may lead to 
cell disappearance by an unknown mechanism independent of T3 transport. Use of the related transporter y + LAT1 
that transports an overlapping spectrum of amino acids as LAT1 but without the T3 transport (Hennemann, 2001) may 
formally rule out the alternate explanation. The positive correlations of LAT1 expression with hind limb, tail, and 
intestine remodeling may signify a role in TH signaling especially in those tissues, but may also reflect a greater need 
for amino acid transport during tissue remodeling. Indeed, LAT1 was highly expressed after metamorphic climax (NF 
stage 66) when intestine may require amino acid transport in the intestine. Teasing apart the impact of one role versus 
the other for LAT1 is a challenge for future experiments. 
In contrast to LAT1, overexpression of MCT8 did not increase the rate of T3-induced cell disappearance. The 
explanation for this discrepancy between LAT1 and MCT8 is not clear but may be related to different transport rates 
across the cell membrane. TH uptake by MCT8 may quickly reach equilibrium because significant TH efflux out of 
cells occurs (Visser et al., 2007), but efflux by LAT1 is limited potentially enabling LAT1-overexpressing cells to 
achieve a higher intracellular TH level (Meier et al., 2002). Further testing to establish such a mechanism is required. 
Overexpression of CRYM and PKM2 increased tail muscle cell disappearance in a T3-dependent manner, which is 
consistent with facilitating shuttling T3 from the cytoplasm to the nucleus for TR binding. This is in contrast with 
previous in vitro studies showing CRYM- and PKM2-dependent decreased transcription from T3 response genes 
(Ashizawa et al., 1991; Mori et al., 2002). The in vivo mechanisms of these multifunction proteins need further work 
and may be explored with mutants, such as the PKM2KE mutant, which retains kinase activity but cannot bind T3 
(Christofk et al., 2008). 
For MCT8 + CRYM, we observed a huge effect, where MCT8 + CRYM increased the amount of cell disappearance to 
a great extent even in the 0 nM T3 treatment. Our statistical analysis showed a lack of a significant T3 effect because of 
the high variation. Also, the interaction we observed (namely, the difference in cell disappearance between 
MCT8 + CRYM and control was 88% to 57% (31%) in the absence of T3 compared to 65% to 18% (47%) in the 
presence of T3) was not statistically significant due to high variation in the experiment. Nevertheless, our 
MCT8 + CRYM results are congruent with previous cell culture studies, where co-transfection of MCT8 plus CRYM 
had a greater transcriptional effect than either CRYM or MCT8 alone (Van Mullem et al., 2011). We hypothesize that 
MCT8 + CRYM is very effective at sensitizing cells to T3, such that the low level of endogenous T3 was sufficient to 
induce cell disappearance in tail muscle cells overexpressing MCT8 + CRYM in our assay. 
 
5. Conclusions 
We used expression profiles, expression levels, and functional assays to assess the possible role of six THTs and 
CTHBPs in regulating the timing of TH-induced developmental change. Our expression analysis showed that in no 
case was a THT or a CTHBP or even TRβ itself always correlated with the timing of metamorphic change across all 
tissues but did suggest a role in TH-dependent development of some of these TH signaling proteins for some tissues. In 
accord with its extremely high sensitivity to TH, the hind limb had the largest number of mRNAs measured favoring 
TH sensitivity that were highly expressed at the time of TH-dependent development, namely LAT1, MCT8, CRYM, 
OATP1c1 from our study as well as TRα and deiodinase type 2 from previous studies (Cai and Brown, 2004; Wang 
and Brown, 1993). Similarly, the brain is very sensitive to TH as judged by neuron proliferation early in 
metamorphosis and expresses high levels of LAT1, OATP1c1, PKM2, MCT8, and CRYM mRNA. The least sensitive 
organ, the tail, expresses lower levels of THTs and CTHBPs among tissues, and the expression of MCT8 and CRYM 
dramatically increases at the time of tail resorption at the end of metamorphosis. The other organs, which transform in 
between the extremes of hind limb and tail, had fewer THT or CTHBP expression patterns that correlated with the 
timing of their transformation. As with expression profiles, expression level differences among tissues for a THT or 
CTHBP may suggest that tissues may vary in the significance a particular TH signaling protein has for TH sensitivity. 
The brain had high levels of LAT1, PKM2, CRYM, and OATP1c1 mRNA, whereas the liver and intestine had high 
ALDH1 mRNA levels, suggesting a role in those tissues perhaps affecting TH signaling. 
Our in vivo functional assays suggested that LAT1, PKM2, CRYM, and likely CRYM + MCT8 have the potential to 
increase T3-dependent cell disappearance. A potential mechanism underlying this effect on cell disappearance is that 
these genes may increase cell sensitivity/responsivity to T3. Furthermore, based on these results from the tail, 
expression of these genes in other tissues would sensitize cells to T3 and accelerate transformation in those tissues. On 
the other hand, the known dual functions of LAT1, PKM2, and CRYM leave open the possibility that such augmented 
cell disappearance may not solely be due to increasing TH bioavailability in the cell nucleus. In conclusion, each tissue 
examined appears to have a unique deployment of TH-signaling proteins, some of which we have shown to affect TH-
dependent development in vivo, potentially underlying tissue-specific developmental timing during metamorphosis. 
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